tiprankstipranks
Trending News
More News >
Max Healthcare Institute Ltd (IN:MAXHEALTH)
:MAXHEALTH
India Market
Advertisement

Max Healthcare Institute Ltd (MAXHEALTH) Stock Forecast & Price Target

Compare
3 Followers
See the Price Targets and Ratings of:

MAXHEALTH Analyst Ratings

Hold
5Ratings
Hold
2 Buy
2 Hold
1 Sell
Based on 5 analysts giving stock ratings to
Max
Healthcare Institute Ltd
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MAXHEALTH Stock 12 Month Forecast

Average Price Target

₹1,291.40
▲(9.21% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Max Healthcare Institute Ltd in the last 3 months. The average price target is ₹1,291.40 with a high forecast of ₹1,500.00 and a low forecast of ₹1,140.00. The average price target represents a 9.21% change from the last price of ₹1,182.45.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"879":"₹879","1190":"₹1,190","1501":"₹1,501","1034.5":"₹1,034.5","1345.5":"₹1,345.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1500,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.50K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1291.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.29K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.14K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[879,1034.5,1190,1345.5,1501],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1246.95,1266.4153846153847,1285.8807692307694,1305.3461538461538,1324.8115384615385,1344.2769230769231,1363.7423076923078,1383.2076923076922,1402.673076923077,1422.1384615384616,1441.6038461538462,1461.0692307692307,1480.5346153846153,{"y":1500,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1246.95,1250.3692307692309,1253.7884615384617,1257.2076923076925,1260.626923076923,1264.0461538461539,1267.4653846153847,1270.8846153846155,1274.3038461538463,1277.723076923077,1281.1423076923077,1284.5615384615385,1287.9807692307693,{"y":1291.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1246.95,1238.7230769230769,1230.496153846154,1222.2692307692307,1214.0423076923078,1205.8153846153846,1197.5884615384616,1189.3615384615384,1181.1346153846155,1172.9076923076923,1164.6807692307693,1156.4538461538461,1148.226923076923,{"y":1140,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":952.3,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":921.59,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":880.73,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":967.88,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1015.48,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1018.47,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1018.47,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1138.24,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1061.02,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":977.72,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1094.94,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1278.12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1246.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target₹1,500Average Price Target₹1,291Lowest Price Target₹1,140
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on IN:MAXHEALTH
TR | OpenAI - 4o
TR | OpenAI - 4o
₹1,350₹1,212
Hold
2.50%
Upside
Reiterated
08/27/25
AI Generated ArticleAI Generated Article
Kotak Mahindra Analyst forecast on IN:MAXHEALTH
Kotak Mahindra
Kotak Mahindra
₹1,070₹1,140
Sell
-3.59%
Downside
Reiterated
08/18/25
Kotak Mahindra Remains a Sell on Max Healthcare Institute Ltd (MAXHEALTH)
Jefferies Analyst forecast on IN:MAXHEALTH
Jefferies
Jefferies
₹1,400₹1,500
Buy
26.86%
Upside
Reiterated
08/14/25
Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,500.00 (from INR1,400.00) while maintaining a Buy rating.
Citi
₹1,250₹1,460
Buy
23.47%
Upside
Reiterated
08/11/25
Citi Remains a Buy on Max Healthcare Institute Ltd (MAXHEALTH)
HSBC
₹1,055₹1,145
Hold
-3.17%
Downside
Reiterated
07/17/25
HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)
J.P. Morgan Analyst forecast on IN:MAXHEALTH
J.P. Morgan
J.P. Morgan
₹1,390₹1,325
Buy
12.06%
Upside
Reiterated
05/22/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.
Bank of America Securities Analyst forecast on IN:MAXHEALTH
Bank of America Securities
Bank of America Securities
₹1,100₹1,170
Hold
-1.05%
Downside
Reiterated
05/21/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.
Macquarie
₹615
Sell
-47.99%
Downside
Reiterated
03/28/25
Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on IN:MAXHEALTH
TR | OpenAI - 4o
TR | OpenAI - 4o
₹1,350₹1,212
Hold
2.50%
Upside
Reiterated
08/27/25
AI Generated ArticleAI Generated Article
Kotak Mahindra Analyst forecast on IN:MAXHEALTH
Kotak Mahindra
Kotak Mahindra
₹1,070₹1,140
Sell
-3.59%
Downside
Reiterated
08/18/25
Kotak Mahindra Remains a Sell on Max Healthcare Institute Ltd (MAXHEALTH)
Jefferies Analyst forecast on IN:MAXHEALTH
Jefferies
Jefferies
₹1,400₹1,500
Buy
26.86%
Upside
Reiterated
08/14/25
Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,500.00 (from INR1,400.00) while maintaining a Buy rating.
Citi
₹1,250₹1,460
Buy
23.47%
Upside
Reiterated
08/11/25
Citi Remains a Buy on Max Healthcare Institute Ltd (MAXHEALTH)
HSBC
₹1,055₹1,145
Hold
-3.17%
Downside
Reiterated
07/17/25
HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)
J.P. Morgan Analyst forecast on IN:MAXHEALTH
J.P. Morgan
J.P. Morgan
₹1,390₹1,325
Buy
12.06%
Upside
Reiterated
05/22/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.
Bank of America Securities Analyst forecast on IN:MAXHEALTH
Bank of America Securities
Bank of America Securities
₹1,100₹1,170
Hold
-1.05%
Downside
Reiterated
05/21/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.
Macquarie
₹615
Sell
-47.99%
Downside
Reiterated
03/28/25
Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Max Healthcare Institute Ltd

1 Month
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+7.27%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +7.27% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+5.30%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.30% per trade.
1 Year
Bansi DesaiJ.P. Morgan
Success Rate
2/2 ratings generated profit
100%
Average Return
+11.95%
reiterated a buy rating 3 months ago
Copying Bansi Desai's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +11.95% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+11.95%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +11.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MAXHEALTH Analyst Recommendation Trends

Rating
Feb 25
Mar 25
May 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
2
2
1
5
7
Hold
1
1
2
3
5
Sell
2
2
2
1
1
Strong Sell
0
0
0
0
0
total
5
5
5
9
13
In the current month, MAXHEALTH has received 7 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. MAXHEALTH average Analyst price target in the past 3 months is 1,291.40.
Each month's total comprises the sum of three months' worth of ratings.

MAXHEALTH Financial Forecast

MAXHEALTH Earnings Forecast

Next quarter’s earnings estimate for MAXHEALTH is ₹4.80 with a range of ₹4.80 to ₹4.80. The previous quarter’s EPS was ₹3.15. MAXHEALTH beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year MAXHEALTH has Outperformed its overall industry.
Next quarter’s earnings estimate for MAXHEALTH is ₹4.80 with a range of ₹4.80 to ₹4.80. The previous quarter’s EPS was ₹3.15. MAXHEALTH beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year MAXHEALTH has Outperformed its overall industry.

MAXHEALTH Sales Forecast

Next quarter’s sales forecast for MAXHEALTH is ₹27.12B with a range of ₹27.12B to ₹27.12B. The previous quarter’s sales results were ₹20.28B. MAXHEALTH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.93% of the time in the same period. In the last calendar year MAXHEALTH has Preformed in-line its overall industry.
Next quarter’s sales forecast for MAXHEALTH is ₹27.12B with a range of ₹27.12B to ₹27.12B. The previous quarter’s sales results were ₹20.28B. MAXHEALTH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.93% of the time in the same period. In the last calendar year MAXHEALTH has Preformed in-line its overall industry.

MAXHEALTH Stock Forecast FAQ

What is IN:MAXHEALTH’s average 12-month price target, according to analysts?
Based on analyst ratings, Max Healthcare Institute Ltd’s 12-month average price target is 1,291.40.
    What is IN:MAXHEALTH’s upside potential, based on the analysts’ average price target?
    Max Healthcare Institute Ltd has 9.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Max Healthcare Institute Ltd a Buy, Sell or Hold?
          Max Healthcare Institute Ltd has a consensus rating of Hold, which is based on 2 buy ratings, 2 hold ratings and 1 sell ratings.
            What is Max Healthcare Institute Ltd’s share price target?
            The average share price target for Max Healthcare Institute Ltd is 1,291.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹1,500.00 ,and the lowest forecast is ₹1,140.00. The average share price target represents 9.21% Increase from the current price of ₹1,182.45.
              What do analysts say about Max Healthcare Institute Ltd?
              Max Healthcare Institute Ltd’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Max Healthcare Institute Ltd?
                To buy shares of IN:MAXHEALTH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis